A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis
Clinical trial NCT03678688 · COMPLETED
Trial details
- NCT number
- NCT03678688
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-18
- Primary completion
- 2022-02-14
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.